QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction.
QIAmini is the third new QIAGEN sample preparation system launched in 2026. It follows QIAsprint Connect for high-throughput research sample processing and QIAsymphony Connect for medium-throughput ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction. Building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results